American Well Corp SEC Filings

American Well Corp's Chief Accounting Officer, Paul Francis McNeice, reported an open-market sale of 130 shares of Class A common stock at $5.24 per share on March 2, 2026. According to the filing, the sale was an automatic “sell to cover” transaction to pay taxes from restricted stock units vesting on March 1, 2026 and was not a discretionary trade. After this tax-related sale, he directly holds 2,933 shares of Class A common stock.

American Well Corporation submitted a Form 144 notice reporting a proposed sale of 15,890 shares of Class A common stock tied to the vesting of a restricted stock unit grant on 03/01/2026. The filing lists Morgan Stanley (1 New York Plaza) and notes the class trades on the NYSE.

American Well Corporation filed a Form 144 reporting proposed sales of Class A Common Stock.

The notice lists securities-related activity tied to restricted stock unit vesting and prior transfers, including a RSU vesting of 6,786 shares on 03/01/2026 and examples of transfers: Phyllis Gotlib – 3,707 shares on 01/02/2026 and 3,574 shares on 12/01/2025.

Form 144 notice: A Rule 144 notice lists proposed and recent sales of common stock tied to broker Morgan Stanley Smith Barney LLC and an individual, Dmitry Zamansky. The notice shows a past sale of 6,243 common shares on 01/02/2026 for $30,278.55 and a separate listed block of 2,472 common shares dated 04/18/2022.

American Well Corp received an amended Schedule 13G/A showing updated ownership and voting power for Dr. Ido Schoenberg and Dr. Roy Schoenberg. Ido Schoenberg is reported as beneficially owning 831,642 shares, or 5.4% of the Class A equivalent, while Roy Schoenberg is reported as beneficially owning 892,499 shares, or 5.7%.

Their holdings include both Class A and Class B Common Stock, plus options for additional Class B shares that are currently exercisable. Class B shares are convertible into Class A shares at any time at the holder’s option. As of December 31, 2025, there were 14,782,788 shares of Class A Common Stock outstanding.

The brothers are parties to a voting agreement to vote their shares together as a group. Through the special voting structure of the Class B shares, they each hold 25.5% of the total outstanding voting power, and together control 51% of the aggregate voting power of American Well’s outstanding share capital.

American Well Corporation (Amwell) files its annual report describing a hybrid digital care platform used by about 50 health plans covering over 90 million lives and roughly 80 large health systems. Since inception, it has supported more than 37.6 million virtual visits, including 4.5 million in 2025.

Amwell estimates a roughly $94 billion U.S. digital care market, with about $31 billion of platform opportunity expected to grow to $50 billion, plus a sizable virtual clinical services segment. The report details competition across telehealth, EHR, big tech and behavioral health, and outlines extensive U.S. and international healthcare, privacy and data security regulation.

Amwell highlights a January 2025 divestiture of its APC telepsychiatry business for an upfront $20.7 million plus an additional revenue-based payment, and the wind-down of its Cleveland Clinic joint venture. The company reports 562 employees as of December 31, 2025 and emphasizes ESG initiatives around people, products and operations.

Senvest Management, LLC and Richard Mashaal report a 5.0% beneficial stake in American Well Corp’s Class A Common Stock. They report beneficial ownership of 737,589 shares, based on 14,723,951 shares outstanding as of October 24, 2025, with shared voting and dispositive power over all reported shares.

The shares are held through Senvest Master Fund, LP and Senvest Technology Partners Master Fund, LP, for which Senvest Management acts as investment manager and Mashaal is the managing member. They certify the holdings are not for the purpose of changing or influencing control of American Well.

American Well Corporation reported fourth-quarter and full-year 2025 results showing sharply reduced losses and improving efficiency. Q4 2025 revenue was $55.3 million with a 51% gross margin, and net loss narrowed to $25.2 million, compared with $31.9 million in the third quarter. Adjusted EBITDA improved to $(10.3) million from $(12.7) million in the prior quarter, with total visits of 1.0 million.

For full-year 2025, revenue was $249.3 million, gross margin was 53%, and net loss declined to $95.0 million from $212.6 million in 2024. Adjusted EBITDA improved to $(39.9) million from $(134.4) million, on 4.5 million total visits, and year-end cash and short-term securities were about $182.3 million.

For 2026, Amwell guides revenue to $195–$205 million, AMG visits to 1.32–1.37 million, and adjusted EBITDA to $(24)–$(18) million, with Q1 2026 revenue of $48–$53 million and adjusted EBITDA of $(7)–$(5) million. Management also targets positive cash flow from operations in the fourth quarter of 2026.

American Well Corp received a Schedule 13G filing showing that investment entities associated with Jacob Ma-Weaver have accumulated a meaningful stake in the company. Funicular Funds, LP, Cable Car Capital, LP, and Jacob Ma‑Weaver each report beneficial ownership of 810,551 shares of Class A common stock, representing 5.5% of the class, based on 14,723,951 shares outstanding as disclosed in a prior Form 10‑Q. Each reporting person has sole voting and dispositive power over these shares and no shared power. They certify that the shares were not acquired to change or influence control of American Well, but instead are being reported on a passive basis.